Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Todd Neale

November 02, 2023

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

Presentation TCT 2023

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

Presenter: Tobias Koch

October 26, 2023

Presentation TCT 2023

TCT 277: Comparison of Change in Side-Branch Ostium after Drug-Coated Balloon versus Drug-Eluting Stent versus Medication for the Treatment of De Novo Coronary Bifurcation Lesions

Presenter: Ae-Young Her

October 26, 2023

Presentation TCT 2023

TCT 80: The Everolimus Eluting Synergy MegatronTM Drug-eluting Stent Platform for Aorto-ostial and Proximal Coronary Disease – Early Outcomes from the European Synergy MegatronTM Implanters' Registry

Presenter: Matthew Li Kam Wa

October 26, 2023

Presentation TCT 2023

TCT 250: Transradial versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using Second-generation Drug-eluting Stent

Presenter: Jun-Won Lee

October 26, 2023

Presentation TCT 2023

TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis

Presenter: Aakash Garg

October 25, 2023

Presentation TCT 2023

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

Presenter: Rayyan Hemetsberger

October 25, 2023

Presentation TCT 2023

TCT 255: Sex differences in procedural characteristics and clinical outcomes among patients undergoing bifurcation PCI using second-generation drug-eluting stents

Presenter: Hyun Jin Ahn

October 25, 2023

Presentation TCT 2023

TCT 424: In Vitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting from Intravascular Lithotripsy

Presenter: Doosup Shin

October 25, 2023

Presentation TCT 2023

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

Presenter: Eline Ploumen

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

Presentation TCT 2023

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

Presenter: Seong Huan Choi

October 25, 2023

Presentation TCT 2023

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Presenter: Byeong-Keuk Kim

October 25, 2023

Presentation TCT 2023

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Presenter: Shao-Liang Chen

October 25, 2023

Presentation TCT 2023

Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial

Presenter: Myeong-Ki Hong

October 25, 2023

Presentation TCT 2023

TCT 649: Impact of a Novel Hybrid Nano-coated Nitinol Drug-eluting Stent (Hybrid-DES) on Below-the-knee Atherosclerotic Disease: 2023 Update

Presenter: Terumitsu Hasebe

October 25, 2023

Advertisement

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

TCT 277: Comparison of Change in Side-Branch Ostium after Drug-Coated Balloon versus Drug-Eluting Stent versus Medication for the Treatment of De Novo Coronary Bifurcation Lesions

TCT 80: The Everolimus Eluting Synergy MegatronTM Drug-eluting Stent Platform for Aorto-ostial and Proximal Coronary Disease – Early Outcomes from the European Synergy MegatronTM Implanters' Registry

TCT 250: Transradial versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using Second-generation Drug-eluting Stent

TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

TCT 255: Sex differences in procedural characteristics and clinical outcomes among patients undergoing bifurcation PCI using second-generation drug-eluting stents

TCT 424: In Vitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting from Intravascular Lithotripsy

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Comparing DCBs in De Novo CAD: Drugs, Design Matter

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial

TCT 649: Impact of a Novel Hybrid Nano-coated Nitinol Drug-eluting Stent (Hybrid-DES) on Below-the-knee Atherosclerotic Disease: 2023 Update

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content